Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mathis Mueller-Ohldach"'
Autor:
Manuela Eicher, Sanna Iivanainen, Maria Reig, Amparo Yovanna Castro Sanchez, Anne-Marie Baird, Bogdana Balas, Alberto Bustillos, Sophie Golding, Mathis Mueller-Ohldach, Manfred Welslau, Johannes Ammann
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Introduction Digital patient monitoring (DPM) tools can enable more effective clinical care and improved patient outcomes in cancer. However, their broad adoption requires ease of use and demonstration of real-world clinical utility/impact. ORIGAMA (
Externí odkaz:
https://doaj.org/article/d84f45f54c0149dcaaf9cd6c718b2e56
Autor:
Sanna Iivanainen, Anne-Marie Baird, Bogdana Balas, Alberto Bustillos, Amparo Yovanna Castro Sanchez, Manuela Eicher, Sophie Golding, Mathis Mueller-Ohldach, Maria Reig, Manfred Welslau, Johannes Ammann
Publikováno v:
BMJ Open. 13:e063242
IntroductionDigital patient monitoring (DPM) tools can enable more effective clinical care and improved patient outcomes in cancer. However, their broad adoption requires ease of use and demonstration of real-world clinical utility/impact. ORIGAMA (M
Autor:
Jeremy Scarato, George Pentheroudakis, Linda Mileshkin, Marlene Thomas, Mathis Mueller-Ohldach, Alwin Krämer, Giulia Baciarello, Chantal Pauli, Holger Moch, Jeffrey S. Ross, George Zarkavelis, Andreas Beringer, Ferran Losa, Suayib Yalcin, Tilmann Bochtler, Mustafa Ozguroglu
Publikováno v:
The Oncologist
Background CUPISCO is an ongoing randomized phase II trial (NCT03498521) comparing molecularly guided therapy versus platinum‐based chemotherapy in patients newly diagnosed with “unfavorable” cancer of unknown primary (CUP). Materials and Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf0a78a3a2c80ec6c871198e270691b0
https://hdl.handle.net/20.500.12831/6561
https://hdl.handle.net/20.500.12831/6561